Navigation Links
Chiltern Wins Two Pharma Awards at the Prestigious Annual Pharmatimes Awards Ceremony

LONDON, Feb. 17, 2012 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Chiltern has won two awards at the PharmaTimes Annual Awards 2011 ceremony held February 16, 2012 at the Park Plaza Riverbank Hotel in London. The competition, established in 1999, celebrates the competence and ability of top clinical research professionals.

Glenn Kerkhof, Chiltern CEO, congratulates all of Chiltern's Award Winners and Finalists. "I couldn't be more proud of every Chiltern colleague nominated for an award and this recognition is a testament to their outstanding abilities. Their achievements support Chiltern's mission to deliver high quality services around the world, while demonstrating our commitment to clients' needs."

Linda Christmas, Sr. Executive VP, Global Resourcing Solutions, Chiltern, stated, "I am delighted that our finalists represent not only Chiltern's outstanding operational people but also our dedicated and professional recruitment team. This further demonstrates not only our ability to deliver world class operational services via our internal teams, but also to place exceptional talent direct with our clients and furthermore an outstanding recruitment and personnel placement service. I am absolutely delighted to be able to work with such a great team each and every day."

Chiltern Award WinnersClinical Recruiter of the Year Bronze Award: Marc Joseph, Resourcing Manager, Chiltern Resourcing Solutions

Clinical Research Associate of the Year Silver Award: Danielle Fairclough, client based Clinical Research Professional via Chiltern Resourcing Solutions

Company profileAbout Chiltern:Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs nearly 1,300 people globally and offers services in Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Chiltern prides itself as a development partner that offers flexibility, responsiveness and quality delivery. Further information is available at:

 For More Information Contact: 

 Natalie Chong

Susan OjanenMarketing Director

Marketing ExecutiveChiltern International Ltd.

Chiltern International Inc.171 Bath Road

1241 Volunteer Parkway, Suite 950Slough, Berkshire SL1 4AA


USATel:  +44 (0) 1753 512 000

Tel:  +1 (423) 968 9533Email:




SOURCE Chiltern
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Chiltern Expands North American Operations With a New Office in Illinois
2. Chiltern - Spectratox Drug Photoxicity Collaboration Celebrates 25 Years
3. Chiltern Wins Multiple Pharma Awards at the Prestigious Annual PharmaTimes Awards Ceremony
4. NABP Supports Legislation Aimed to Protect Patients from Counterfeit Drugs and Fake Online Pharmacies
5. SCOLR Pharma, Inc. Launches Cutting Edge Nutritional Products at Major Retailers in 2012
6. Access Pharmaceuticals MuGard Added to Nationally Ranked Childrens Hospital of Colorado Pharmacy Formulary
7. PDL BioPharma to Announce Fourth Quarter and Full Year 2011 Financial Results on February 23, 2012
8. Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors
9. IntegriChain Delivers Pharmacy Level Inventory Metrics
10. ViroPharma to Release 2011 Fourth Quarter and Full Year Financial Results on February 28, 2012
11. American Academy of Dermatology and LEO Pharma Launch Educational Website to Raise Awareness About Sun Damage and Skin Cancer
Post Your Comments:
(Date:12/1/2015)... Sweden , December 1, 2015 ... Cancer Study Group (IBCSG, Bern ) and ... to be part of a state of the art trial, ... --> --> The study, ... treated with anti-hormonal therapy in combination with palbociclib, a cancer ...
(Date:11/30/2015)... BASEL, Switzerland , Dec. 1, 2015 ... through its wholly-owned UK subsidiary Proximagen Ltd., today announced ... novel, oral small molecule inhibitor of Vascular Adhesion Protein ... in the treatment of inflammatory disease. The VAP-1 inhibitor ... --> --> Under the terms ...
(Date:11/30/2015)... Asia,s largest exhibition and conference dedicated to the Medical Device ... 22 nd April 2016. --> --> ... --> -->   --> --> ... population and the government back up, the Medical Device is one of the ... . With the aging population and the government back up, the Medical ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator ... the latest addition to the devices for sale in the United States. Clarity ... and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is easy to ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... has selected 10 semi-finalists to head to Las Vegas for CES 2016, the world’s ... including CEO of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica ...
(Date:12/1/2015)... ... 2015 , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, has ... The order will be from the China Disabled Persons’ Federation, a central government association, ... solution for children and adults suffering from severe and profound hearing loss . ...
(Date:12/1/2015)... ... December 01, 2015 , ... Tympani Inc., announced ... (ATP) status from Cisco. This designation recognizes Tympani as having fulfilled the training ... solutions targeted to the high-end enterprise contact center marketplace. , Ed Kapelinski, President ...
(Date:11/30/2015)... , ... November 30, 2015 , ... Trevor and Taylor ... as they play for the chance to represent the United States. This hybrid ... to be a part of their journey in addition to offering corporate sponsors with ...
Breaking Medicine News(10 mins):